Indian court rejects AstraZeneca’s injunction request

24-11-2020

Sarah Morgan

Indian court rejects AstraZeneca’s injunction request

Tada Images / Shutterstock.com

The Delhi High Court has refused to grant AstraZeneca an injunction against the manufacture and sale of dapagliflozin by a group of India-based pharmaceutical companies.


AstraZeneca, dapagliflozin, diabetes, Delhi High Court, injunction, patent validity, Torrent Pharmaceutical, Micro Labs, Zydus Healthcare, Eris Lifescience

LSIPR